Â鶹ӳ»­

MD Anderson and Xilis announce strategic collaboration to advance novel technology and accelerate therapeutic development

Preclinical research agreement brings together Xilis¡¯ MicroOrganoSphere? platform with MD Anderson¡¯s expertise in cancer research and therapeutic development